Verena Schmitt
Essen, NW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Insights into circulating CEACAM1 in insulin clearance and disease progression: Evidence from the Portuguese PREVADIAB2 study.
Journal: European journal of clinical investigation
Published: September 16, 2024
Gut-to-brain spreading of pathology in synucleinopathies: A focus on molecular signalling mediators.
Gut-to-brain spreading of pathology in synucleinopathies: A focus on molecular signalling mediators.
Journal: Behavioural brain research
Published: March 10, 2023
Antibody ligation of CEACAM1, CEACAM3, and CEACAM6, differentially enhance the cytokine release of human neutrophils in responses to Candida albicans.
Journal: Cellular immunology
Published: July 23, 2021
Evaluation of carcinoembryonic antigen-related cell adhesion molecule 1 blood serum levels in women at high risk for preeclampsia.
Journal: American journal of reproductive immunology (New York, N.Y. : 1989)
Published: August 24, 2020
Bacterial protein domains with a novel Ig-like fold target human CEACAM receptors.
Journal: The EMBO journal
Published: June 30, 2020
Fluorophore-conjugated Helicobacter pylori recombinant membrane protein (HopQ) labels primary colon cancer and metastases in orthotopic mouse models by binding CEA-related cell adhesion molecules.
Journal: Translational oncology
Published: June 09, 2020
Cysteine Residues in Helicobacter pylori Adhesin HopQ are Required for CEACAM-HopQ Interaction and Subsequent CagA Translocation.
Journal: Microorganisms
Published: February 12, 2020
Type IV secretion of Helicobacter pylori CagA into oral epithelial cells is prevented by the absence of CEACAM receptor expression.
Journal: Gut pathogens
Published: February 06, 2020
Last Updated: 09/26/2026